Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025
Include: 3 videos + 19 pdfs, size: 42 GB
Target Audience: physicians specializing in: family or general practice, internal medicine, endocrinology, geriatric medicine, lipidology, hypertension
Information:
29th Annual Hypertension, Diabetes, & Dyslipidemia Conference
Explore the flavors, sights, sounds and traditions that define Savannah’s heart and soul at the 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference, set against the backdrop of enchanting Savannah, Georgia from June 18-20, 2025. Join fellow healthcare professionals at the Hyatt Regency for a transformative CME-accredited experience, surrounded by the city’s historic charm, vibrant culture, and unmatched southern hospitality. With half-day meetings, afternoons are your own to explore Savannah’s charming streets, enjoy award-winning low country cuisine, and unwind.
The target audience for the 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference in 2025 includes a wide range of healthcare professionals who manage patients with these chronic conditions:
👩⚕️👨⚕️ Primary Attendees
- Physicians specializing in:
- Family or General Practice
- Internal Medicine
- Endocrinology
- Geriatric Medicine
- Lipidology
- Hypertension
- Advanced Practice Providers:
- Nurse Practitioners (NPs)
- Physician Assistants (PAs)
🎯 Focus Areas
- Clinical updates and treatment strategies for:
- Hypertension
- Diabetes
- Dyslipidemia
- Controversies and evolving guidelines in chronic disease management
- Improving patient outcomes through evidence-based care
Faculty
Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Division of Cardiology
Medical University of South Carolina
Ralph H Johnson VA Medical Center
Previous Vice-Chair of Clinical Programs AHA Council of Hypertension
US National Leader SURPASS-CVOT
Charleston, SC
More about Jan N. Basile, MD, FACP, FASH, FAHA
Assistant Professor of Medicine, Harvard Medical School
Medical Director, Comprehensive Hypertension Center
Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center
Boston, MA
More about Jennifer L. Cluett, MD, FAHA
Professor of Medicine with Tenure
James A. Keating Endowed Chair in Diabetes
Director, Division of Endocrinology, Diabetes & Metabolic Diseases
Medical University of South Carolina
Charleston, SC
More about Marc-Andre Cornier, MD
Professor, Charles E. Butterworth, Jr.
Professor of Medicine, Department of Nutrition Sciences
University of Alabama at Birmingham
Director/PI, UAB Diabetes Research Center
Birmingham, AL
More about W. Timothy Garvey, MD, MACE
Daniel W. Jones, MD, MACP, FAHA
Dean and Professor Emeritus
University of Mississippi School of Medicine
Jackson, MS
More about Daniel W. Jones, MD, MACP, FAHA
Professor of Medicine
Cardiologist and Lipidologist
Director, Advanced Lipid Disorders Program
Ciccarone Cener of Prevention of Cardiovascular Disease
Professor, Johns Hopkins School of Medicine
Baltimore, MD
More about Seth Martin, MD, MHS, FACC, FAHA, FASPC
Executive Director for Research, Providence Health Care
Co-Principal Investigator of the Institute of Translation Health Services
Professor of Medicine
Kidney Research Institute and University of Washington
Spokane, WA
More about Katherine R. Tuttle, MD, FASN, FACP, FNKF
Lipidology & Cardiovascular Disease Prevention
Diplomate American Board of Clinical Lipidology
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President National Lipid Association
President American Board of Clinical Lipidology
New York, NY
More about James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below